{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-006589","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.907678+00:00","generated_at":"2026-06-02T23:30:07.270264+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Owens & Minor Q1 adj EPS $0.19 (4x YoY); revenue $2.61B up 4%","bullets":["Adj EPS $0.19 vs $0.05 YoY; GAAP net loss per share $(0.29) vs $(0.32).","Revenue $2.61B, up 4% YoY; adjusted operating income $57.4M vs $47.7M.","Gross margin expanded 79 bps; adjusted operating margin up 31 bps.","Products & Healthcare Services segment grew, invested in inventory for new customers.","Patient Direct segment delivered mid-single digit top-line growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-006589","json":"https://secwatch.observer/filing/0001558370-24-006589.json","markdown":"https://secwatch.observer/filing/0001558370-24-006589.md","text":"https://secwatch.observer/filing/0001558370-24-006589.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000155837024006589/0001558370-24-006589-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000155837024006589/tmb-20240503x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:30:07.270264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e3cce95d9fabe3c97fa3e000ee4bb4f37efe5b5b","claim":"ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2024 results: revenue $2.6 billion, net income $(0.29) per share.","evidence_excerpt":"VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. ​ Key Highlights: ● Consolidated revenue of $2.6 billion in the first quarter, representing year-over-year growth of 4% ● GAAP operating margin was flat while adjusted operating margin expanded by 31 basis points versus prior year ●","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024006589/0001558370-24-006589-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$2.6 billion"},{"label":"Net income","value":"$(0.29) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}